Literature DB >> 23729686

Influence of sex on the outcome of autologous chondrocyte implantation in chondral defects of the knee.

Peter C Kreuz1, Sebastian Müller, Arvind von Keudell, Thomas Tischer, Christian Kaps, Philipp Niemeyer, Christoph Erggelet.   

Abstract

BACKGROUND: Sex-specific outcomes have been reported in anterior cruciate ligament reconstruction as well as in osteoarthrosis progression, but there are currently no related published data on autologous chondrocyte implantation (ACI). The present prospective study was performed to investigate sex-dependent differences in the results after ACI. HYPOTHESIS: The clinical and magnetic resonance imaging (MRI) results after ACI of the knee are influenced by the patient's sex. STUDY
DESIGN: Cohort study; Level of evidence, 2.
METHODS: The midterm clinical and MRI results of a cell-based fibrin-polymer graft for the treatment of full-thickness cartilage defects were evaluated preoperatively and 6, 12, and 48 months after surgery in 52 patients (male:female ratio, 25:27; average age, 35.6 years). Depending on the sex and the location of the defects (femoral condyles, n = 32; patellofemoral compartment, n = 20), patients were assigned to 4 different groups. Baseline clinical scores were compared with follow-up data by paired Wilcoxon tests for the Lysholm score and the International Knee Documentation Committee (IKDC) scoring system. Sex-specific differences were evaluated with the Mann-Whitney U test. The MRI evaluation was performed with the Henderson score at final follow-up.
RESULTS: Clinical scores improved in all groups over the whole study period (P < .05). Compared with female patients, male patients achieved significantly better results in the Lysholm score at all time intervals and in the IKDC score at 6 and 12 months after surgery (P < .05). In a subgroup analysis, female patients with patellar defects had the worst results in both clinical scores. With the available number of patients, MRI evaluation at 48 months after surgery revealed no significant difference in defect fill between male and female patients (P > .05). The Pearson correlation coefficient between both clinical scores and the MRI parameters of defect fill and cartilage signal was significant (P < .05).
CONCLUSION: Autologous chondrocyte implantation is a promising treatment option for full-thickness cartilage defects of male and female knee joints. Female patients with patellar defects have worse prognostic factors.

Entities:  

Keywords:  autologous chondrocyte implantation; cartilage lesion; cartilage repair; sex

Mesh:

Year:  2013        PMID: 23729686     DOI: 10.1177/0363546513489262

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  25 in total

1.  Revision surgery after third generation autologous chondrocyte implantation in the knee.

Authors:  Thomas R Niethammer; Thomas Niethammer; Siegfried Valentin; Andreas Ficklscherer; Mehmet F Gülecyüz; Mehmet Gülecyüz; Matthias F Pietschmann; Matthias Pietschmann; Peter E Müller; Peter Müller
Journal:  Int Orthop       Date:  2015-05-07       Impact factor: 3.075

2.  Third-generation autologous chondrocyte implantation after failed bone marrow stimulation leads to inferior clinical results.

Authors:  Peter Ernst Müller; David Gallik; Florian Hammerschmid; Andrea Baur-Melnyk; Matthias Frank Pietschmann; Anja Zhang; Thomas Richard Niethammer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-08-12       Impact factor: 4.342

3.  Symptoms and function in patients with articular cartilage lesions in 1,000 knee arthroscopies.

Authors:  Eirik Solheim; Arne Magnus Krokeide; Peder Melteig; Allan Larsen; Torbjørn Strand; Mats Brittberg
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-12-13       Impact factor: 4.342

4.  Chitosan based scaffold applied in patellar cartilage lesions showed positive clinical and MRI results at minimum 2 years of follow up.

Authors:  Alberto Poggi; Alessandro Di Martino; Luca Andriolo; Davide Reale; Giuseppe Filardo; Elizaveta Kon; Stefano Zaffagnini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-06-09       Impact factor: 4.342

5.  Matrix based autologous chondrocyte implantation in children and adolescents: a match paired analysis in a follow-up over three years post-operation.

Authors:  Thomas Richard Niethammer; Martin Holzgruber; Mehmet Fatih Gülecyüz; Patrick Weber; Matthias Frank Pietschmann; Peter Ernst Müller
Journal:  Int Orthop       Date:  2016-11-08       Impact factor: 3.075

6.  Influence of response shift on early patient-reported outcomes following autologous chondrocyte implantation.

Authors:  Jennifer S Howard; Carl G Mattacola; David R Mullineaux; Robert A English; Christian Lattermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-06       Impact factor: 4.342

7.  Wide Variation in Methodology in Level I and II Studies on Cartilage Repair: A Systematic Review of Available Clinical Trials Comparing Patient Demographics, Treatment Means, and Outcomes Reporting.

Authors:  Bryan Michael Saltzman; Michael L Redondo; Adam Beer; Eric J Cotter; Rachel M Frank; Adam B Yanke; Brian J Cole
Journal:  Cartilage       Date:  2018-10-31       Impact factor: 4.634

8.  Significantly worse isokinetic hamstring-quadriceps ratio in patellofemoral compared to condylar defects 4 years after autologous chondrocyte implantation.

Authors:  Sebastian Müller; Anja Hirschmüller; Christoph Erggelet; Nicholas A Beckmann; Peter C Kreuz
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-04-03       Impact factor: 4.342

9.  Impact of guidance documents on translational large animal studies of cartilage repair.

Authors:  Christian G Pfeifer; Matthew B Fisher; James L Carey; Robert L Mauck
Journal:  Sci Transl Med       Date:  2015-10-21       Impact factor: 17.956

10.  Accurate Reporting of Concomitant Procedures Is Highly Variable in Studies Investigating Knee Cartilage Restoration.

Authors:  William L Sheppard; Betina B Hinckel; Armin Arshi; Seth L Sherman; Kristofer J Jones
Journal:  Cartilage       Date:  2019-04-11       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.